Brief: GenSight Biologics Announces Publication Of Review Of Gene Therapy Trials For LHON

Gensight Biologics SA

06/10/2021 06:59

Oct 6 (Reuters) - GENSIGHT BIOLOGICS SA  SIGHT.PA :
    * ANNOUNCES THE PUBLICATION OF A REVIEW OF GENE THERAPY
TRIALS FOR
LHON IN INTERNATIONAL OPHTHALMOLOGY CLINICS
    * BILATERAL TREATMENT EFFECT FOLLOWING UNILATERAL INJECTION
OF
GENE THERAPY FOR ND4-LHON WAS INDEPENDENTLY REPORTED BY THREE
RESEARCH GROUPS
    * ACROSS THESE CLINICAL TRIALS,  DIFFERENT CLINICAL
DEVELOPMENT
PROGRAMS, SUSTAINED, CLINICALLY MEANINGFUL BILATERAL BENEFIT WAS
REPORTED IN SUBSTANTIAL PROPORTION OF ND4 PATIENTS

Source text for Eikon:  ID:nBwbJz4yWa 
Further company coverage:  SIGHT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))